These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 798649)

  • 21. [Evaluation of the therapeutic action of flufenamic acid in patients with chronic polyarthritis in a double blind study].
    Mathies H; Eichhorn M
    Med Monatsschr; 1967 Nov; 21(11):510-6. PubMed ID: 4893773
    [No Abstract]   [Full Text] [Related]  

  • 22. [Perclusone in the treatment of inflammatory and degenerative diseases of the locomotor system].
    Szulc EJ
    Wiad Lek; 1977 Feb; 30(2):93-5. PubMed ID: 138262
    [No Abstract]   [Full Text] [Related]  

  • 23. Double-blind comparison of ibuprofen and phenylbutazone in a short-term treatment of rheumatoid arthritis.
    Pavelka K; Susta A; Vojtísek O; Brémová A; Kanková D; Hándlová D; Malecek J
    Arzneimittelforschung; 1973 Jun; 23(6):842-6. PubMed ID: 4579953
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical evaluation of 17190RP (protizinic acid) in chronic rheumatoid arthritis].
    Shiokawa Y; Okazaki T; Iwasaki Y
    Ryumachi; 1977 Jan; 17(1):63-79. PubMed ID: 322318
    [No Abstract]   [Full Text] [Related]  

  • 25. Niflumic acid in the management of rheumatoid arthritis.
    Sood OP; Gulati PD; Chandra S; Shah SN; Vaishnava H
    J Assoc Physicians India; 1973 Oct; 21(10):841-7. PubMed ID: 4601610
    [No Abstract]   [Full Text] [Related]  

  • 26. [Procedure for the evaluation of anti-inflammatory and analgesic agents for the treatment of chronic rheumatoid arthritis: a standard adopted by the Drug Evaluation Committee of the Japan Rheumatism Association].
    Shichikawa K; Sugawara S; Azuma T; Aritomi H; Igarashi M; Ichikawa Y; Saito T; Torisu T; Nishioka K; Maoda A
    Ryumachi; 1983 Aug; 23(4):254-67. PubMed ID: 6364387
    [No Abstract]   [Full Text] [Related]  

  • 27. [Mefenamic acid in the therapy of rheumatoid arthritis. Clinical experiments and biohumoral control with the double-blind method. (Preliminary observations)].
    D'Ingianna E
    Reumatismo; 1967; 19(3):180-2. PubMed ID: 4890710
    [No Abstract]   [Full Text] [Related]  

  • 28. [On pharmacological clinical studies of the effectiveness of non-steroid anti-inflammatory agents in rheumatoid arthritis].
    Stroescu V
    Med Interna (Bucur); 1974 Jan; 26(1):5-10. PubMed ID: 4821151
    [No Abstract]   [Full Text] [Related]  

  • 29. A new pyrazolidine derivative - benetazone spofa - in short- and medium-term treatment of rheumatoid arthritis. (Double-blind comparative study with phenylbutazone).
    Pavelka K; Vojtisek O; Bremová A; Kauková D; Hándlová D
    Int J Clin Pharmacol Biopharm; 1976 Jul; 14(1):20-8. PubMed ID: 61951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [4-prenyl-1,2-diphenyl-3,5-pyrazolidindione (DA 2370) in rheumatoid arthritis: clinical study with the use of a new weighted articular index].
    Cerri B; Bianchi G; Chierichetti S
    Reumatismo; 1972; 24(3):217-24. PubMed ID: 4549698
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical trial of Midalgyl in rheumatology].
    Verhaeghe A; Delcambre B
    Lille Med; 1971 Apr; 16():S 2:638-9. PubMed ID: 5317348
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of 19583RP (ketoprofen) in the treatment of chronic rheumatoid arthritis].
    Shiokawa Y; Abe T; Onoda T
    Ryumachi; 1974 Oct; 14(3):279-86. PubMed ID: 4615379
    [No Abstract]   [Full Text] [Related]  

  • 33. [What can we expect from an anti-inflammatory agent after 3 years of experimentation and rheumatologic practice?].
    Weissenbach R
    Therapeutique; 1972 Dec; 48(10):685-8. PubMed ID: 4540974
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bufexamac in the treatment of progressive polyarthritis. Double-blind test using phenylbutazone, too].
    Pavelka K; Vojtísek O; Brémová A; Hándlová D; Kanková D; Králová M
    Cas Lek Cesk; 1972; 111(22):514-7. PubMed ID: 5031749
    [No Abstract]   [Full Text] [Related]  

  • 35. Rheumatoid arthritis--observations on clinical features and management.
    Luhar PM; Patel AC
    Indian Pract; 1965 Sep; 18(9):655-9. PubMed ID: 5320594
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antirheumatic non-steroid drugs in the treatment of rheumatoid arthritis].
    Dormidontov EN; Korshunov NI; Baranova EIa
    Ter Arkh; 1978; 50(9):10-3. PubMed ID: 705637
    [No Abstract]   [Full Text] [Related]  

  • 37. Feprazone compared with indomethacin in the management of rheumatoid arthritis.
    Sturrock R; Isaacs A; Hart FD
    Practitioner; 1975 Jul; 215(1285):94-7. PubMed ID: 1103113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of a new non-steroid anti-inflammatory agent in the treatment of inflammation of gynecological origin].
    Cianti F; Ceccarelli P; Rossi M
    Minerva Ginecol; 1975 Feb; 27(2):172-6. PubMed ID: 1094327
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of thermography in the evaluation of the anti-inflammatory activity of feprazone on rheumatoid arthritis.
    Singer F; Gruber J; Graber J; Reinthaler M; Thumb N
    Arzneimittelforschung; 1982; 32(4):427-9. PubMed ID: 7201815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinico-therapeutic experiences with a new anti-inflammatory agent: DA 2370].
    Scanni A; Ferrari P
    Minerva Med; 1973 Oct; 64(71):3718-24. PubMed ID: 4588363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.